Altimmune Inc (ALT)

8.265 +0.08 (+1.04%) USD  |  NASDAQ  |  Dec 20, 16:00
8.30 +0.04 (+0.42%) After-Hours: 20:00
More

Altimmune Price to Book Value: 4.407 for Dec. 20, 2024

Price to Book Value Chart

View Price to Book Value for ALT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price to Book Ratio Definition

View Price to Book Ratio Definition
Start Trial

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
NovaBay Pharmaceuticals Inc 2.429
Palatin Technologies Inc --
iBio Inc 1.278
Theriva Biologics Inc 0.1288
Oragenics Inc 2.921

Price to Book Value Related Metrics

PS Ratio 10780.69
PEG Ratio -2.702
Price 8.265
Earnings Yield -19.00%
Market Cap 587.84M